ICU Medical, Inc., a manufacturer of disposable medical connection systems for use in vascular therapy applications, today confirmed that it has received FDA 510-k clearance for the Neutron Neutral-Pressure Needleless Connector.
ICU Medical, Inc., a manufacturer of disposable medical connection systems for use in vascular therapy applications, today confirmed that it has received FDA 510-k clearance for the Neutron Neutral-Pressure Needleless Connector. The new connector incorporates patented technology from ICU Medical that is designed to prevent all types of blood reflux in a catheter, including line or syringe disconnection, patient vascular pressure changes caused by coughing or sneezing, as well as an IV bag running dryall of which are associated with catheter patency.
As a neutral-pressure device, the use of the Neutron may help hospitals address Food and Drug Administration (FDA) concerns about the safety of positive-displacement needleless connectors and their possible connection to higher rates of device-associated bloodstream infections (BSI). Following three reports of deaths associated with BSI and positive displacement needleless connectorsand increased concerns raised by infection control authorities including the Society for Healthcare Epidemiologists of America and Infectious Disease Society of Americathe FDA last week ordered manufacturers of positive displacement connectors to conduct a post-market surveillance study on the safety of these devices.1
In addition to the device's neutral-pressure features, the Neutron also incorporates a pre-slit septum that was recently noted in the 2010 Draft CDC Guidelines for the Prevention of Intravascular Catheter-Related Infections as being a preferred design feature to aid in the prevention of bloodstream Infections.2
ICU Medical, Inc. expects to conduct expanded clinical beta testing of the Neutron with select customers in the third quarter of 2010.
References:
1. FDA Medical Device Safety Alert, July 28, 2010: Letter to Infection Control Practitioners Regarding Positive Displacement Needleless Connectors (http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm220459.htm)
2. Guideline for the Prevention of Intravascular Catheter-Related Bloodstream Infections, Final Issue Review, May 17, 2010 (http://www.cdc.gov/hicpac/pdf/BSI_guideline_IssuesMay17final.pdf)
Pseudomonas aeruginosa: Infection Risks, Challenges, and Breakthroughs for Health Care Professionals
September 19th 2024Pseudomonas aeruginosa, a highly virulent pathogen, poses significant risks to immunocompromised patients, presenting challenges in treatment due to its antibiotic resistance and environmental persistence.
Advancing Infection Prevention With Diagnostic Innovation: Insights From Alesia McKeown, PhD
September 17th 2024Alesia McKeown, PhD, discusses the pivotal role of cutting-edge diagnostic technologies in enhancing infection prevention, especially in high-risk health care environments, during an interview with Infection Control Today.
The Role of Accurate Testing in Preventing Respiratory Illnesses: Insights from Dr. Aparna Ahuja
September 17th 2024On Get Ready for Flu Day, Dr. Aparna Ahuja discusses the importance of accurate respiratory illness testing, the risks of self-diagnosis, and the role of infection prevention personnel in public health education.
How Cleaning Medical Equipment Directly Affects Patient Safety and Equipment Longevity
September 16th 2024Hospital-associated infections affect over 1 million US patients annually. Proper medical equipment cleaning and sterilization significantly reduce infection risks, improving patient outcomes and safety.
Top 3 Secrets to Effective Infection Prevention and Control Through Strategic MDRO Surveillance
September 13th 2024Sean Brown’s 2024 Disease Prevention Summit presentation emphasized leveraging technology, prioritizing high-risk patients, and environmental surveillance to enhance infection prevention and control strategies.